- SPICE-III🇦🇺 No mortality benefit, ?merit in older MV patient
- 🆕A2B 🇬🇧no difference in early extubation
Dexmed as an adjunct:
- DahLIA🇦🇺early extubation in agitated MV pt
- DESIRE🇯🇵 no mortality benefit in septic pt on MV
🆕on @jama.com
jamanetwork.com/journals/jam...
- SPICE-III🇦🇺 No mortality benefit, ?merit in older MV patient
- 🆕A2B 🇬🇧no difference in early extubation
Dexmed as an adjunct:
- DahLIA🇦🇺early extubation in agitated MV pt
- DESIRE🇯🇵 no mortality benefit in septic pt on MV
🆕on @jama.com
jamanetwork.com/journals/jam...
journals.sagepub.com/doi/10.1177/...
journals.sagepub.com/doi/10.1177/...
In this multicentre ICU cohort 🇦🇺(n=216k), frailty (CFS 5–8) was associated with significantly shorter 4-year survival 🕰️💔
🚨 New in BJA:
🔗 authors.elsevier.com/c/1k~Co1dCDy...
@bjajournals.bsky.social
In this multicentre ICU cohort 🇦🇺(n=216k), frailty (CFS 5–8) was associated with significantly shorter 4-year survival 🕰️💔
🚨 New in BJA:
🔗 authors.elsevier.com/c/1k~Co1dCDy...
@bjajournals.bsky.social